TYSON TIMOTHY
Insider CIK 1207405 · BDSI Director · NONE Director, 10% owner · TYME Director · SYRS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2024-06-05 | 2024-06-07 | 4,000 | — | $0 | 33,189 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2023-06-01 | 2023-06-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2023-06-01 | 2023-06-02 | 4,000 | — | $0 | 29,189 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | P Buy | 2022-09-30 | 2022-10-03 | 14,000 | $6.37 | $89.2K | 24,932 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | P Buy | 2022-09-29 | 2022-10-03 | 2,932 | $5.72 | $16.8K | 10,932 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-09-16 | 2023-04-20 | 3,856 | — | $0 | 3,856 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-09-16 | 2023-04-20 | 3,856 | — | $0 | 3,856 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-09-16 | 2023-04-20 | 2,848 | — | $0 | 2,848 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-09-16 | 2023-04-20 | 2,191 | — | $0 | 2,191 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-09-16 | 2023-04-20 | 2,191 | — | $0 | 2,191 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-09-16 | 2023-04-20 | 3,286 | — | $0 | 3,286 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-09-16 | 2023-04-20 | 1,094 | — | $0 | 1,094 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-09-16 | 2023-04-20 | 2,232 | — | $0 | 2,232 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-09-16 | 2023-04-20 | 12,000 | — | $0 | 12,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2022-09-16 | 2023-04-20 | 257 | — | $0 | 8,257 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2022-09-16 | 2023-04-20 | 8,000 | — | $0 | 8,000 | SEC↗ |
| TYME TYME TECHNOLOGIES, INC. | D To issuer deriv | 2022-09-16 | 2022-09-16 | 50,058 | — | $0 | 0 | SEC↗ |
| TYME TYME TECHNOLOGIES, INC. | D To issuer deriv | 2022-09-16 | 2022-09-16 | 25,000 | — | $0 | 0 | SEC↗ |
| TYME TYME TECHNOLOGIES, INC. | D To issuer deriv | 2022-09-16 | 2022-09-16 | 75,000 | — | $0 | 0 | SEC↗ |
| TYME TYME TECHNOLOGIES, INC. | D To issuer deriv | 2022-09-16 | 2022-09-16 | 50,000 | — | $0 | 0 | SEC↗ |
| TYME TYME TECHNOLOGIES, INC. | D To issuer deriv | 2022-09-16 | 2022-09-16 | 50,000 | — | $0 | 0 | SEC↗ |
| TYME TYME TECHNOLOGIES, INC. | D To issuer deriv | 2022-09-16 | 2022-09-16 | 88,000 | — | $0 | 0 | SEC↗ |
| TYME TYME TECHNOLOGIES, INC. | D To issuer deriv | 2022-09-16 | 2022-09-16 | 88,000 | — | $0 | 0 | SEC↗ |
| TYME TYME TECHNOLOGIES, INC. | D To issuer deriv | 2022-09-16 | 2022-09-16 | 65,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-09-16 | 2022-09-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TYME TYME TECHNOLOGIES, INC. | D To issuer | 2022-09-16 | 2022-09-16 | 5,865 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2022-09-16 | 2022-09-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| TYME TYME TECHNOLOGIES, INC. | A Award deriv | 2022-08-24 | 2022-08-29 | 88,000 | — | $0 | 88,000 | SEC↗ |
| TYME TYME TECHNOLOGIES, INC. | A Award deriv | 2021-08-24 | 2021-08-26 | 88,000 | — | $0 | 88,000 | SEC↗ |
| TYME TYME TECHNOLOGIES, INC. | A Award deriv | 2020-08-20 | 2020-08-24 | 65,000 | — | $0 | 65,000 | SEC↗ |
| TYME TYME TECHNOLOGIES, INC. | A Award deriv | 2019-08-22 | 2019-08-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NONE Icagen, Inc. | A Award deriv | 2018-11-14 | 2018-11-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NONE Icagen, Inc. | A Award deriv | 2018-11-14 | 2018-11-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TYME TYME TECHNOLOGIES, INC. | A Award deriv | 2018-08-26 | 2018-08-28 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NONE Icagen, Inc. | A Award deriv | 2018-08-13 | 2018-08-15 | 45,000 | — | $0 | 45,000 | SEC↗ |
| NONE Icagen, Inc. | A Award deriv | 2018-07-13 | 2018-07-17 | 114,284 | — | $0 | 685,704 | SEC↗ |
| NONE Icagen, Inc. | A Award deriv | 2018-07-13 | 2018-07-17 | 114,284 | — | $0 | 685,704 | SEC↗ |
| TYME TYME TECHNOLOGIES, INC. | A Award deriv | 2018-05-24 | 2018-05-29 | 75,000 | — | $0 | 75,000 | SEC↗ |
| NONE Icagen, Inc. | A Award deriv | 2018-04-04 | 2018-04-06 | 571,428 | — | $0 | 571,428 | SEC↗ |
| NONE Icagen, Inc. | A Award deriv | 2018-04-04 | 2018-04-06 | 571,428 | — | $0 | 571,428 | SEC↗ |
| NONE Icagen, Inc. | A Award deriv | 2017-12-29 | 2018-01-02 | 5,357 | $0.02 | $107 | 5,357 | SEC↗ |
| NONE Icagen, Inc. | P Buy | 2017-12-29 | 2018-01-02 | 21,428 | $0.37 | $7.9K | 164,284 | SEC↗ |
| TYME TYME TECHNOLOGIES, INC. | A Award deriv | 2017-11-22 | 2017-11-27 | 50,958 | — | $0 | 50,958 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise deriv | 2017-08-14 | 2017-08-16 | 3,658 | — | $0 | 3,657 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | M Exercise | 2017-08-14 | 2017-08-16 | 3,658 | — | $0 | 4,658 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | A Award deriv | 2017-07-14 | 2017-07-18 | 7,315 | — | $0 | 7,315 | SEC↗ |
| BDSI BIODELIVERY SCIENCES INTER | A Award deriv | 2017-07-14 | 2017-07-18 | 3,658 | $2.64 | $9.7K | 3,658 | SEC↗ |
| NONE Icagen, Inc. | A Award deriv | 2017-04-12 | 2017-04-14 | 75,000 | — | $0 | 75,000 | SEC↗ |
| NONE Icagen, Inc. | A Award deriv | 2017-03-15 | 2017-03-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NONE Icagen, Inc. | A Award deriv | 2016-07-07 | 2016-07-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NONE Icagen, Inc. | A Award deriv | 2016-05-19 | 2016-05-20 | 12,500 | — | $0 | 12,500 | SEC↗ |
| NONE XRpro Sciences, Inc. | A Award deriv | 2015-01-07 | 2015-01-09 | 71,428 | — | $0 | 71,428 | SEC↗ |
| NONE XRpro Sciences, Inc. | A Award | 2015-01-07 | 2015-01-09 | 285,712 | — | $0 | 285,712 | SEC↗ |
| NONE Caldera Pharmaceuticals In | A Award deriv | 2014-04-01 | 2014-04-04 | 132,000 | — | $0 | 132,000 | SEC↗ |